RxDoctor Payments Data

David Bryant

Anatomic Pathology & Clinical Pathology · Phoenix, AZNPI 1114911211

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,176 of the $1,903 with a category attached, or 61.8%. AbbVie accounts for 85.8% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2024 at $1,412 and has fallen 67.1% since, to $465 in 2025.

$1,903in general payments, 2019–2025

Across 18 payments — averaging $105.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Roche Molecular Systems, Inc.$182
  • Organon$38
  • Kyowa Kirin, Inc.$27
  • Dermavant Sciences, Inc.$23
$691,603in research payments, 2019–2025

Across 14 payments — averaging $49,400 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Ventana Medical Systems, Inc.$692K

What the payments were for

  • Travel & lodging$1,17662%
  • Food & beverage$72738%

General payments by program year

21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,903 in reported general payments places this provider in the 80th percentile of 153 anatomic pathology & clinical pathology providers in Arizona.

See all anatomic pathology & clinical pathology providers in Arizona

Other anatomic pathology & clinical pathology in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →